Search results for: 'ACCESSIBILITY MARKET'

15 May 2025  |  Global  |  Market Research

Immunomodulator Therapeutics Market, Global, 2024–2030

Mechanism-targeted Approaches are Driving Transformational Growth by Enabling Innovation in Autoimmune, Oncology, and Inflammatory Therapies

Infographics

×

This research service offers a comprehensive analysis of the global immunomodulator therapeutics market, specifically targeting inflammatory disorders in the immunology, gastrointestinal (GI), and dermatology segments. The report defines this market through products designed to modify and regulate pathological immune responses, either by inhibiting...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinfo...

With a population of 620 million, ASEAN represents approximately 8.6% of the global population. With a combined GDP of US$2.4 trillion in 2013, growing at an average annual rate of 5.6%, the region’s economic growth outpaces many other regional and global economies. Demand for healthcare services is expected to surge due to factors such as populati...

Today, the healthcare industry is focused toward patient centric care and preventative healthcare. Preventative healthcare involves regular screening and diagnosis for diseases before the condition becomes fatal. Early diagnosis improves the clinical outcome of the patients, reduces emergency visits, and subsequently healthcare costs. Usually, ear...

This study charts how digital health ecosystems are likely to form and scale through 2040 and what that implies for providers, payers, technology vendors, and retail/community partners. We define a digital health ecosystem as an interoperable platform that coordinates people, data, and decisions across home, retail, and hospital settings—secured by...

The global medical imaging equipment and informatics industry is experiencing increasing demand for primary care, high prevalence of chronic diseases, and high footfall in screening centers, which are driving its growth. 2023 marked an increasing focus on oncology and precision imaging, indicated by the rising procurement of computed tomography (CT...

Mental health conditions reduce people’s life expectancy—yet mental health takes a distant second place to physical health in many instances. This is slowly changing after the COVID-19 pandemic triggered rising cases of anxiety and depression, as have other geopolitical conditions and natural calamities. With rising awareness, new treatments em...

The global pharmaceutical industry strives to build an inclusive partner ecosystem that integrates technology, data, and regulatory standardization-enabled innovation into clinical trial delivery. This transformation aims to reduce the burden on investigators and sites while improving the efficiency and accuracy of adverse event (AE) tracking. Driv...